Eli Lilly (LLY) Stock Price, Quote, News & History | Benzinga

Eli Lilly and Co (LLY) Stock Price, Quote, News & History

LLYNYSE

Trade with Public

Trade with Public

$1189.41

-44.25-3.59%

At close: Aug 26, 5:00 PM EST

$1189.61

0.200.02%

After Hours: 7:58 PM EST

PRO

Why Is It Moving?™:Eli Lilly shares are trading lower. The company reported a real‑world study...

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$1.23K

Close

$1.19K

Volume / Avg.

3.01M / 2.95M

Day Range

$1.18K - $1.24K

52 Wk Range

694.23 - 1.29K

Market Cap

$1.06T

P/E Ratio

41.41

Dividend Yield

0.56%

Exchange

NYSE

RSI

48

Short Interest

0.74%

Days to Cover

2.11

Recent Eli Lilly and Company News

Obesity Drug Alert: Eli Lilly Study Shows Sustained Zepbound Treatment Reduces Hospital Visits, Medical Costs

New Eli Lilly study reveals that Zepbound significantly lowers monthly healthcare costs for older adults with overweight or obesity.

Vandana Singh

Eli Lilly Stock Pulls Back After Hitting Record Highs Last Week

Eli Lilly and Co. shares are trading lower Wednesday, pulling back from last week's record high despite positive real-world data on Zepbound.

Evette Mitkov

Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. Energy leads, gold sinks 1.3% to $4,599.

Piero Cingari

Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’

Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe recommended Netflix.

Avi Kapoor

Top 3 Health Care Stocks That Could Blast Off This Month

The health care sector's oversold stocks present buying opportunities for undervalued companies. RSI compares stock strength on up and down days, with an RSI below 30 considered oversold.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

28.08B

Investing Cash Flow (TTM)

-25.10B

Financing Cash Flow (TTM)

2.61B

Free Cash Flow (TTM)

13.56B

Capital Expenditure (TTM)

-14.52B

Net Change in Cash (TTM)

5.59B

Analyst Trends and Forecast

5

May

2

Jun

10

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.15T

PE Ratio (TTM)

41.41

PE Ratio (FWD)

34.01

PEG Ratio (TTM)

1.55

PS Ratio (TTM)

13.88

PB Ratio (TTM)

32.46

Earnings Yield % (TTM)

2.41%

Earnings Yield % (FWD)

2.94%

EV / EBITDA (TTM)

27.47

Price / EBITDA (TTM)

26.52

Price / Free Cash Flow (TTM)

81.57

Book Value / Share

$38.01

Company Debt

Total Debt

$54.91B

LT Debt

$47.86B

LT Debt Issuance (TTM)

$15.65B

LT Debt Repayment (TTM)

-$1.62B

Total Cash

$8.95B

Debt to Equity

1.62

Issuance of Debt (TTM)

$14.02B

Repayment of Debt (TTM)

-$1.62B

Key Statistics

Open

$1.23K

Close

$1.19K

Volume / Avg.

3.01M / 2.95M

Day Range

$1.18K - $1.24K

52 Wk Range

694.23 - 1.29K

Market Cap

$1.06T

P/E Ratio

41.41

Dividend Yield

0.56%

Exchange

NYSE

RSI

48

Short Interest

0.74%

Days to Cover

2.11

About

Sector

Health Care

Industry

Pharmaceuticals

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometaboli...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Eli Lilly (LLY) stock?

A

You can purchase shares of Eli Lilly (NYSE:LLY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Eli Lilly (LLY) competitors?

A

Other companies in Eli Lilly’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).

Q

What is the forecast, or price target, for Eli Lilly (LLY) stock?

A

Eli Lilly has a consensus price target of $1237.45.

Q

What is the current price for Eli Lilly (LLY)?

A

The stock price for Eli Lilly (NYSE: LLY) is $1189.6071 last updated August 26, 2026 at 7:58 PM EDT.

Q

Does Eli Lilly (LLY) pay a dividend?

A

There are no upcoming dividends for Eli Lilly.

Q

When is Eli Lilly (NYSE:LLY) reporting earnings?

A

Eli Lilly does not have any upcoming earnings scheduled.

Q

Is Eli Lilly (LLY) going to split?

A

There is no upcoming split for Eli Lilly.

Q

What sector and industry does Eli Lilly (LLY) operate in?

A

Eli Lilly is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.